Cardiology Archives - Page 2 of 6

Hospital mortality in COVID-19 patients in Belgium treated with statins, ACE inhibitors and/or ARBs

Authors: G Byttebier, L Belmans, M Alexander, B E H Saxberg, B De Spiegeleer, A De Spiegeleer, N Devreker, J T Van Praet, K Vanhove, R Reybrouck, E Wynendaele, D S Fedson...

Hospital admissions for stroke and bleeding in Hounslow following a quality improvement initiative

Authors: https://openheart.bmj.com/content/8/1/e001558 Published: Open Heart, 2021 View publication

Adjunctive use of statins for COVID-19

Authors: M Sathekge, G Byttebier, B De Spiegeleer, B Saxberg, V Ueckermann, L Belmans, M Alexander, D Fedson Published: Journal of Clinical Medicine, 2021 View publication The interaction between obesity, cardiometabolic disorders...

Cardiovascular healthcare cost savings associated with increased whole grains consumption among adults in the United States

Authors: M M Murphy, J K Schmier Published: Nutrients, 2020 View publication Abstract Little is known about the potential health economic impact of increasing the proportion of total grains consumed as whole...

Statin intake and all-cause mortality among older nursing home residents

Authors: A De Spiegeleer, J Van Migerode, A Bronselaer, E Wynendaele, M Peelman, F Vandaele, G Byttebier, G De Tré, L Belmans, C Van De Wiele, M Sathekge, D Van Dijck, B...

Comparison of clinical outcomes of edoxaban versus apixaban, dabigatran, rivaroxaban, and vitamin K antagonists in patients with atrial fibrillation in Germany: a real-world cohort study

Authors: X L Marston, R Wang, Y-C Yeh, L Zimmermann, X Ye, X Gao, B Brüggenjürgen, M Unverdorben Published: International Journal of Cardiology, 2022 View publication Background The aim of the study...

Current management of atrial fibrillation: an observational study in NHS primary care

Authors: G Kassianos, C Arden, S Hogan, R Dew, A Fuat Published: BMJ Open, 2013 View publication Objective To describe National Health Service (NHS) resource use and pharmacological management of atrial fibrillation...

Cost-utility analysis of genotype-guided antiplatelet therapy in patients with moderate-to- high risk acute coronary syndrome and planned percutaneous coronary intervention

Authors: V Patel, F-J Lin, O Ojo, S Rao, S Yu, L Zhan, D R Touchette Published: Pharmacy Practice, 2014 View publication Background Prasugrel is recommended over clopidogrel in poor/intermediate CYP2C19 metabolizers...

Cost-effectiveness of statin therapy for secondary prevention among patients with coronary artery disease and baseline LDL-C 70–100 mg/dL in Taiwan

Authors: F-J Lin, K-G Shyu, I-C Hsieh, W H-H Sheu, S-T Tu, S-J Yeh, C-I Chen, K-C Lu, C-C Wu, W-Y Shau, T J Inocencio, Y-C Wen, H-I Yeh Published: Journal of...

News